Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

By LabMedica International staff writers
Posted on 04 Feb 2026

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. More...

Its high selectivity, sensitivity, and accuracy make it indispensable for complex assays such as steroid hormone analysis, vitamin D measurement, and therapeutic drug monitoring, where even minor variations can influence clinical decisions. Historically, however, mass spectrometry has required specialized expertise and labor-intensive workflows, limiting its adoption in routine clinical laboratories. A new collaboration now aims to overcome these barriers by introducing a fully automated mass spectrometry platform to U.S. clinical labs.

Labcorp, a global provider of comprehensive laboratory services, announced that it has become the first U.S. commercial laboratory to enter into an agreement to implement Roche’s cobas Mass Spec solution. The collaboration brings fully automated mass spectrometry into routine clinical practice, enabling faster turnaround times, improved analytical accuracy, and broader access to advanced diagnostic testing for patients and healthcare providers nationwide.

The cobas Mass Spec solution will initially be deployed at Labcorp’s Burlington, North Carolina laboratory, with a launch expected in the first quarter of 2026, followed by phased expansion to additional Labcorp locations. The agreement builds on the long-standing collaboration between Labcorp and Roche and reinforces Labcorp’s commitment to delivering innovative technologies across its Diagnostics and Biopharma Laboratory Services business segments.

Roche’s cobas® Mass Spec solution is a fully automated, integrated in-vitro diagnostics system that brings complex mass spectrometry testing into routine clinical laboratories. It combines the cobas® i 601 analyzer with Ionify® reagents to manage the full workflow from sample preparation to results, eliminating manual steps and reducing complexity and turnaround times. The platform is designed to support a broad and expanding test menu, with approximately 60 assays planned. It is also engineered for future integration with clinical chemistry and immunochemistry analyzers.

“Labcorp is committed to advancing diagnostic science through transformative technologies,” said Marcia Eisenberg, Ph.D., Labcorp’s chief scientific officer. “Integrating Roche’s automated mass spectrometry solution will enable us to deliver greater accuracy and efficiency for critical tests that guide treatment decisions and improve patient outcomes.”

“This collaboration reflects our shared vision to make advanced diagnostics widely accessible,” said Brad Moore, President and CEO, Roche Diagnostics North America. “Together, we are setting a new benchmark for accuracy, reliability and efficiency in patient care.”

Related Links
Roche
Labcorp


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.